What Is Mesothelioma?

(PRLEAP.COM) Mesothelioma is still a relatively rare form of cancer. There are an estimated 2,000 - 3,000 new cases per year in the United States. Approximately 7-13 per one million male patients with a history of asbestos exposure contract mesothelioma. Diagnosis usually occurs 20-40 years after initial exposure to asbestos. For these reasons, it is important for American males to understand the basics of this disease.

The Mesothelioma Reporter has announced the launch of a special report, "What Is Mesothelioma?’. The report is available online at http://www.mesotheliomareporter.org/2004/03/what_is_mesothe.html at no cost. The information within explains the basics of pleural mesothelioma, peritoneal mesothelioma, and pericardial mesothelioma, and describes the symptoms related to this asbestos-related disease.

The guide was edited by Jimmy Atkinson of The Mesothelioma Reporter ( http://www.mesotheliomareporter.org ). "Mesothelioma is a deadly disease, so if someone has asbestos exposure-related symptoms, it is important that they understand the importance of seeking medical help quickly,’ said Atkinson.

Dotmarketer LLC is a privately held company based in Los Angeles, California. For more information, please visit http://www.dotmarketer.com . Visit The Mesothelioma Reporter at http://www.mesotheliomareporter.org or view the report at http://www.mesotheliomareporter.org/2004/03/what_is_mesothe.html .
Contact Information
Jimmy Atkinson
Dotmarketer LLC
(818) 716-2739
Email Dotmarketer LLC

About This News Release

If you have any questions regarding information in these press releases please contact the organization listed in the press release. Issuers of press releases and not PR Leap are solely responsible for the accuracy of the content.

Share this News
PR Leap is a service of Condesa, Inc. © 2009 All Rights Reserved. Use of our service is governed by our Privacy Policy and Terms of Service.
Issuers of news releases are solely responsible for the accuracy of their content. Copyright / IP Policy